CD4 and Hepatitis: Hutchinson et al. reported an enrichment of CMV-associated TEM CD4 populations in the peripheral blood of patients who further developed hepatitis in their cohort [12], instigating a provocative suggestion whether introduction of selective antivirals against Herpesviridae might be beneficial in the prevention or therapy of checkpoint-related immune hepatitis.